Brainstorm Cell Therapeutics Inc.
BCLI- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001137883
No open-market purchases or sales by Brainstorm Cell Therapeutics Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Q3 2021 vs. Q2 2021
How the institutions holding Brainstorm Cell Therapeutics Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 57 | 52 | −5 |
| Shares | 5.63M | 5.13M | −495.4K (−8.8%) |
| Value | $21.4M | $16.9M | −$4.46M (−20.8%) |
New holders (5)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pura Vida Investments, LLC | 106,834 | $353.0K | 0.03% |
| Susquehanna International Group, LLP | 39,031 | $129.0K | 0.00% |
| Walleye Capital LLC | 10,639 | $35.0K | 0.00% |
| Occudo Quantitative Strategies LP | 10,168 | $34.0K | 0.00% |
| FMR LLC | 666 | $2.00K | 0.00% |
Sold out (10)
Institutions that held Brainstorm Cell Therapeutics Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
| Institution | Shares, Q2 2021 | Value, Q2 2021 |
|---|---|---|
| Tibra Equities Europe Ltd | 87,000 | $331.0K |
| First Trust Advisors LP | 74,691 | $284.0K |
| Renaissance Technologies LLC | 47,600 | $181.0K |
| Jane Street Group, LLC | 12,543 | $48.0K |
| ExodusPoint Capital Management, LP | 12,696 | $48.0K |
| Advisory Services Network, LLC | 11,800 | $45.0K |
| LMR Partners LLP | 11,735 | $45.0K |
| Citigroup Inc | 2,750 | $10.0K |
| Cypress Capital Management LLC (WY) | 1,000 | $4.00K |
| New York State Common Retirement Fund | 273 | $1.00K |